Baseline characteristics of participants
| Control | HBPR | p-value | |
| Participants | 30 | 33 | |
| Female | 18 (60) | 16 (48.5) | 0.360 |
| Age years | 49.27±14.10 | 44.42±16.16 | 0.209 |
| BMI kg·m−2 | 24.02±2.91 | 23.96±2.56 | 0.933 |
| MRC score | 2.90±0.92 | 2.48±1.03 | 0.097 |
| Aetiology | |||
| Idiopathic | 15 (50) | 7 (21) | |
| Recurrent pneumonia | 6 (20) | 9 (27) | |
| Gastro-oesophageal reflux disease | 4 (13) | 1 (3) | |
| Other causes | 5 (17) | 16 (49) | |
| MRC score | 0.366 | ||
| 1 | 1 (3.3) | 6 (18.2) | |
| 2 | 10 (33.3) | 11 (33.3) | |
| 3 | 11 (36.7) | 11 (33.3) | |
| 4 | 7 (23.3) | 4 (12.1) | |
| 5 | 1 (3.3) | 1 (3.0) | |
| FACED score | 2.50±1.04 | 2.27±1.23 | 0.431 |
| Mild/moderate severity | 15 (50)/15 (50) | 16 (49)/17 (51) | |
| E-FACED score | 2.57±1.19 | 2.45±1.37 | 0.730 |
| Mild/moderate severity | 24 (80)/6 (20) | 26 (79)/7 (21) | 0.905 |
| Pseudomonas colonisation | 14 (46.7) | 10 (30.3) | 0.189 |
| FVC L | 2.35±0.81 | 2.59±0.97 | 0.296 |
| FVC % pred | 68.90±20.57 | 72.30±21.89 | 0.527 |
| FEV1 L | 1.37±0.56 | 1.63±0.84 | 0.151 |
| FEV1 % pred | 51.21±0.56 | 55.15±27.19 | 0.535 |
| FEV1/FVC | 59.09±14.30 | 61.47±16.49 | 0.542 |
| ISWT m | 433.79±145.74 | 477.40±196.88 | 0.319 |
| ESWT min | 8.22±6.87 | 8.14±6.90 | 0.961 |
| MIST total steps | 115.92±71.74 | 141.94±93.89 | 0.230 |
| Daily steps | 6045±2731 | 7340±4754 | 0.186 |
| Quadriceps strength kg-force | 26.46±12.15 | 26.52±10.76 | 0.983 |
Data are presented as n, n (%) or mean±sd, unless otherwise stated. HBPR: home-based pulmonary rehabilitation; BMI: body mass index; MRC: Medical Research Council dyspnoea scale; FACED: forced expiratory volume in 1 s (FEV1), age, chronic colonisation by Pseudomonas aeruginosa, radiological extension and dyspnoea; E-FACED: FACED criteria plus exacerbation; FVC: forced vital capacity; ISWT: incremental shuttle walk test; ESWT: endurance shuttle walk test; MIST: modified incremental step test.